The gene for ubiquitin hydrolase on the X chromosome (UHX1), cloned and mapped to Xp21.2-p11.2, is a candidate gene for retinal diseases. We used fine mapping techniques to localise UHX1 between markers DXS1266 and DXS337, where congenital stationary night blindness (XlCSNB) and retinitis pigmentosa type 2 (RP2) are also located. Reevaluation of the UHX1 gene structure demonstrated five new exons, for a total of 21 exons and a predicted protein product of 963 amino acids. Evaluation of patients revealed no UHX1 mutations using SSCP (10 CSNB1 and 20 XLRP) or deletion screening with cDNA hybridisation (13 CSNB1 and 43 XLRP). Likewise, no aberrations were found in the nearby PCTAIRE1 (PCTK1) gene in 13 CSNB1 and 43 XLRP patients by deletion screening. Thus mutations of UHX1, and probably PCTK1, do not appear to cause common X-linked eye diseases. UHX1's role in patients with mental retardation may be appropriate for further investigations into UHX1 function.
Introduction
Ubiquitin hydrolases are a group of enzymes found in multiple tissues and involved in regulation of cellular protein function through cleavage of ubiquitin from its conjugated forms. These enzymes thus play an important role in protein degradation and reversible protein modification. A novel gene encoding a ubiquitin C-terminal hydrolase on the X chromosome (UHX1) has recently been described. 1 A widespread tissue expression with a five-to ten-fold higher expression in the retina was shown. Because of this high retinal expression and evidence suggesting abnormalities in protein processing as the etiology of several retinal diseases, 1 UHX1 was proposed as a candidate gene for retinal diseases. Another gene in this region, PCTAIRE-1 (PCTK1), is a member of PCTAIRE, a subfamily of the cdc2-related serine-threonine specific protein kinase family and involved in cell cycle regulation.
2 UHX1, ubiquitin activating enzyme E1 (UBE1) and PCTK1 3 have all previously been mapped to Xp21.2-p11.2, a region known to contain several retinal diseases, including X-linked congenital stationary night blindness, [4] [5] [6] [7] X-linked retinitis pigmentosa types 2 and 3 (RP2, RP3) [8] [9] [10] [11] and X-linked cone dystrophy (XLCOD), 12 (for review see Rosenfeld et al. 13 ). In addition to UHX1's possible retinal function, recent data suggest a role for ubiquitin C-terminal hydrolase in long-term facilitation in Aplysia.
14 This investigation into learning and memory pathways in a mollusk model might carry important implications for causation of mental retardation, learning disorders and memory disturbances in humans. Interestingly, several X-linked mental retardation families also map to this region of the X chromosome (for review see Lubs et al. 15 ) including one family with XLMR and XLRP. 16 Thus the actual function(s) of UHX1 in neurologic and possibly other pathways is at present unclear.
Our investigation explores several aspects of UHX1 and PCTK1 gene structure and function. The possible role of UHX1 involvement in learning and memory is still preliminary and beyond the scope of this investigation. We concentrated instead on the possible causation of retinal disease by UHX1 and PCTK1. First, we performed fine mapping of these two genes to determine exactly which of the retinal diseases localised to this region of the X chromosome might be caused by UHX1 or PCTK1 mutations. Next, determination of the precise genomic structure was done to allow accurate identification of gene defects. Finally, mutation screening was performed to examine the possible causative role of UHX1 and PCTK1 in CSNB1 or RP2, the retinal diseases located in the same region. 18 inserts from both clones were obtained by using vector-specific primers. Hybridisation of patient DNA was carried out in Church buffer with stringent washing conditions (0.1 ϫ SSC).
Materials and Methods

Probes and Hybridisation
Mapping Panels and PACs
Radiation-induced somatic cell hybrids A19D9 and A19E8 were generated as described. 19 Polymorphic microsatellites used for characterisation are contained in the Généthon human linkage map. 20 The ICRF-and CEPH YACs used as mapping resources ( Figure 1) were obtained from RLDB, Berlin. 18 PACs containing the markers DXS1264, DXS1003, DXS1266, DXS337, and ELK1 were isolated from the deJong PAC library by the Sanger Centre (http://www.sanger.ac.uk/ HEP/Chr.X/; Xctg311, Xctg448, Xctg597) and distributed by RLDB, Berlin; PACs containing DXS8237E and/or UHX1 were isolated by hybridisation from the deJong PAC library and provided by RLDB, Berlin.
Identification and Analysis of Genomic Clones
The Lawrence Livermore X cosmid library distributed by RLDB, Berlin, was hybridised with a partial UHX1 cDNA. Hybridisation with the 5' and 3' parts of the published UHX1 cDNA revealed a complete representation of UHX1 on cosmid LLNL c110E2210Q. This cosmid was sequenced after subcloning in pUC vectors. The pUC clones were shotgunsequenced using dye-terminator chemistry. The sequences were assembled and edited with the XGAP program. 21 Gaps were closed using custom-made primers on pUC templates, PCR-products or cosmid DNA. The finished sequence revealed a contig of 41536 base pairs (GDB acc. no. U62534). Exon-intron boundaries were obtained by comparing the genomic sequence with the published cDNA sequence and by exon-prediction programs MC-VECTOR, FEXH AND XGRAIL 1a/2.
PCR Reactions and SSCP Analysis
Annealing temperatures for the primer pairs are listed in Table 1 . All 21 exons of the UXH1 gene were amplified under the following conditions: after an initial denaturation for 5 min at 94°C, denaturation was at 94°C for 1 min, annealing at the exon-specific temperature for 1 min and extension at 72°C for 35 cycles. Amplified fragments from all exons were analysed by SSCP 22 using Hydrolink™ (AT Biochem., Malvern, PA, USA) or SERDO-gels (Boehringer-Ingelheim Bioproducts Partnership, Heidelberg). Staining was performed with Sybrgreen (Molecular-Probes Europe BV, Leiden, The Netherlands), and band visualisation was done with Fluorlmager (Molecular Dynamics GmbH, Krefeld, Germany), both according to the manufacturer's recommendations.
DNA samples
DNA was extracted from peripheral blood samples from unrelated patients with X-linked retinal diseases: 43 affected individuals from RP families without RPGR gene mutations (phenotypes as described by Meindl et al., 23 and 13 affected 
Results
Fine Mapping of UHX1 Between the Markers DXS1266 and DXS337
A cDNA probe encompassing the 3' part of the published UHX1 sequence was used to hybridise DNAs from different radiation hybrids, 19 each maintaining different portions of Xp11.4-Xp11. 22 . UHX1 was present on radiation hybrid A19D9, while probes for DXS8237E, 24 , D86969 and R41358 (NCBI ESTs located between the markers DXS1201 and DXS1039) demonstrated no hybridisation signal. The proximal localisation of UHX1 was further confirmed by PFGE analysis, which showed the UHX1 gene together with the ZNF157 gene 17 on a 350 kb Nrul fragment, whilst DXS8237E and D86969 were located on a 700 kb Nrul fragment. DXS8237E and UHX1 also segregated with different Mlul fragments ( Figure 1 and Figure 2 ). The NCBI EST R41358 was mapped to the PAC dJ182B7, which is part of a contig around DXS1055 and DXS1003. It also identified the 700 kb Nrul fragment and 3 Mb Mlul fragment in genomic DNA, but was not present in a constructed PAC contig encompassing the region between the markers DXS1266 and UHX1. Thus, DXS1055 and DXS1003 were clearly distal to the marker DXS1266. The IMAGE clone D86869, which also identified the large Mlul fragment and the 700 kb Nrul fragment, was mapped to the PAC dJ228K12, suggesting a localisation of this EST between DXS1003 and DXS8237E. PACs containing the markers DXS1264 (dJ182B7), DXS1003 (dJ250J21), DXS1266 (dJ228K12), DXS337 (dJ395N6) and ELK1 (dJ282I11) were identified using the Acedb software of Sanger Centre (X chromosome status map: 45000 kb-47000 kb); PACs containing the genes DXS8237E, PCTK1 and/or UHX1 were isolated from 26, 27 Deletion of ICRF YAC y900C1228 was shown by PFGE analysis.
UXH1 and PCTK1
O Brandau et al t the deJong PAC library and provided by RLDB, Berlin (see Figure 1: dJ439R12, dJ237A9, dJ203K18) .
The new localisation of UHX1 between DXS1266 and DXS337 in Xp11.23 excluded it as a candidate gene for RP3 and XLCOD, and narrowed the field of possibly-related retinal diseases to RP2 and CSNB1. 4, 6, 25 Genomic structure of the UHX1 gene Close linkage of UHX1 to DXS8237E and PCTK1 was shown by the hybridisation of these genes to the PAC dJ237A9. All genes were found on this PAC, while PAC dJ203K18 contained only UHX1 and PCTK1, indicating a small distance between these two genes ( Figure 1) . To determine the genomic structure of the UHX1 gene, two UHX1 cosmids from the Lawrence Livermore library (LLXN01) were isolated. Both cosmids were shown by PCR also to contain the PCTK1 gene which maps close to the ubiquitin activating enzyme E1 gene (UBE1). UHX1 was originally described as a 3121 bp DNA sequence with a 2070 bp open reading frame (ORF), coding for a 690 amino acid sequence (1, Acc.No.:HSU44839). In this report, the ORF was preceded by a 679 bp 5' untranslated region (UTR) and a 410 bp 3'UTR containing an atypical polyadenylation signal and ending with nine adenines. Our data indicate that the previously published cDNA needs to be adjusted at the following positions: G at nucleotide 35 to A, G at nucleotide 47 to C, delete G at nucleotide 55, GC at nucleotides 111 and 112 to CG, insert G at nucleotide 212, insert G at nucleotide 262, insert G at nucleotide 292, insert G at nucleotide 302, and GC at nucleotides 342 and 343 to CG. These inaccuracies led to the prediction of a long 5'UTR and an altered ORF designation. We amplified our own cDNA sequence isolated from brain (GIBCO) encompassing the entire 5'UTR, and reanalysed it for intron-exon boundaries using cosmid sequencing and computer analysis (Table 2, Figure 3 ). Five previously undescribed exons were thereby identified, extending in the 5' direction. The new findings showed that the ORF frame consisted of 3023 bp with a total coding region of 2889 bp and a 5'UTR 134 bp long. All exons, spread over 16 kb (Figure 3a) , could be identified by the gene structure programs XGRAIL2 and FEXH, except exon 1. Exon 1 was recognised by GRAIL1a, although this program did not identify the exon-intron boundaries of the predicted exons accurately. No promoter region could be detected by either XGRAIL 2 or PROMOTER-SCAN II (Figure 3b ).
Genomic Structure of the PCTK1 gene
Full sequencing of the UHX1-containing cosmid revealed a second gene close to the UHX1 gene ( Figure 3 ). This gene consists of at least 15 exons and a t homology search demonstrated identity with the previously published PCTK1 cDNA. 3 Exon-intron boundaries of the 15 exons are described in Table 2 . Again all exons, except exon 2 and 5, could be predicted by FEXH and XGRAIL1a/2 computer analysis. No promoter region was identified, probably due to insufficient sequence data in the 5' direction (Figure 3a) . A combination of our data with that of Carrel et al 3 indicates that the UHX1 gene is located 17 kb from the UBE1 gene.
Mutation Analysis of UHX1 and PCTK1 in Patients with Retinal Disorders
To examine the possible causative role of UHX1 in retinal diseases mapped to Xp21.2-p11.2, DNA samples from patients with XLRP (43 cases) and XLCSNB (13 cases) were digested with EcoRI and PstI and hybridised with the UHX1 cDNA probe. From the 43 XLRP families linked to the RP3 and RP2 region, only 30-40% can be expected to be of the RP2 type, even after exclusion of RPGR mutations.
No aberrations of the UHX1 gene were detected in any of the patient samples using this technique. Hybridisation revealed one fragment of 9 kb with the 5' probe and two fragments of 3 and 12 kb with the 3' probe. In 20 of the 43 XLRP and 10 of the 13 XLCSXIB patients, all 21 exons from the UHX1 gene were amplified with 18 primer pairs (Table 3) . No sequence changes could be detected in any patient analysed by SSCP analysis. All 43 XLRP and 13 XLCSNB patients were also screened for intragenic deletions in the PCTK1 gene using a cDNA probe. A single 20 kb EcoRI fragment and two Pstl fragments of 2 kb and PCTK1 belongs to the cdc2-related protein family, which is involved in the regulation of mitosis. 2 So far, no diseases associated with mutations of the PCTAIRE subfamily have been described.
Comparison of the mapping databases did not allow construction of a consensus map for the region around UXH1. Preliminary PFGE mapping experiments indicated UHX1 as the most centromeric marker, followed by PCTK1 and UBE1. Two new findings helped determine the orientation of the markers: the location of markers DXS1003 and DXS1055 telomeric to UXH1 and DXS8237E, and UHX1's centromeric position relative to DXS8237E. The proximity of UHX1 to PCTK1, and TIMP1 to ARAF1 suggested a different orientation from that published by Carrel et al, 3 possibly because their study used a YAC (ICRF-YAC y900C1228) 26 since shown to be deleted [own data]. The localisation of UHX1 and PCTK1 limited their candidacy to RP2 and CSNB1 and excluded RP3 and XLCOD. No aberrations could be detected for UHX1 by SSCP analysis, or by deletion screening for UHX1 and PCTK1. Evaluation for point mutations in PCTK1 is underway. Thus, UHX1, and to a lesser extent PCTK1, are unlikely to cause retinal diseases. We did not exclude other mechanisms by which retinal diseases might still be caused by these two genes, such as the possibilities of either mutations in the as yet unidentified promoter regions for the two genes or another retinal disease mapping to Xp21.2-p11.2. In addition, the finding of four different genes (UHX1, PCTK1, UBE1 and EST DXS8237E) within 70 kb indicates a gene-rich region, leaving a number of candidate genes for RP2 and CSNB1 to be explored.
A recent report by Hegde et al 14 indicates that ubiquitin C-terminal hydrolase is essential for longterm facilitation in the mollusc Aplysia. Therefore, UHX1 might be a candidate for investigations of human learning and memory, especially syndromal and non-specific X-linked mental retardation (XLMR) already mapped to this region. 15, 16 The role of UHX1 in the regulation of normal growth and cancer development, suggested by Swanson et al, 1 may also be appropriate for future studies.
In summary, we present important new data which enabled the precise genetic structure of UHX1, and the fine mapping, which is an important prerequisite to establish a sequence ready map for the RP2 region. Abnormalities in UHX1 and PCTK1 are unlikely to be the cause of XLRP2 or XLCSNB. Other possible functions of UHX1 in memory, learning, and normal and neoplastic growth remain to be explored.
